Format

Send to

Choose Destination
Value Health. 2014 Jul;17(5):634-41. doi: 10.1016/j.jval.2014.04.006. Epub 2014 Jun 30.

Improving the contribution of regulatory assessment reports to health technology assessments--a collaboration between the European Medicines Agency and the European network for Health Technology Assessment.

Author information

1
European Medicines Agency, London, UK. Electronic address: michael.berntgen@ema.europa.eu.
2
La Haute Autorité de Santé, Saint-Denis La Plaine Cedex, France.
3
National Health Care Institute, Diemen, The Netherlands.
4
European Medicines Agency, London, UK.
5
EUnetHTA Secretariat, C/o Danish Health and Medicines Authority, Copenhagen, Denmark.

Abstract

In response to a recommendation from the Pharmaceutical Forum, the European Medicines Agency and the European network for Health Technology Assessment initiated a collaboration with the aim to improve the contribution regulatory assessment reports can make to the assessment of relative effectiveness of medicinal products by health technology assessment bodies. This collaboration on improving European Public Assessment Reports (EPARs) started in February 2010 and was performed over 2 years. As a result, the templates for preparing EPARs were revised to better address the needs of heath technology organizations. The better understanding of information needs was a key outcome of the collaboration. To ascertain whether these template changes led to the inclusion of relevant information, a review of a small set of EPARs for recently approved medicinal products was carried out in parallel by both the European network for Health Technology Assessment and the European Medicines Agency. This report provides an account of this project on improving EPARs, which is part of the ongoing dialogue between regulators and health technology assessment bodies on a European level to support policymaker decisions in the future.

KEYWORDS:

European Medicines Agency (EMA); European Public Assessment Reports (EPARs); European network for Health Technology Assessment (EUnetHTA); relative effectiveness assessment

PMID:
25128058
DOI:
10.1016/j.jval.2014.04.006
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center